Drug profile · INN
suzetrigine
JOURNAVX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
suzetrigine (JOURNAVX) is an FDA-listed pharmaceutical active ingredient. Associated with Vertex Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN suzetrigine
Brand JOURNAVX
Route ORAL
Formulation TABLET
Originator Vertex Pharmaceuticals (Ireland) Limited
Frequently asked questions
What is suzetrigine?
suzetrigine (JOURNAVX) is an FDA-listed pharmaceutical active ingredient. Associated with Vertex Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for suzetrigine?
JOURNAVX is a marketed brand name for suzetrigine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of suzetrigine?
suzetrigine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.